1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Evolution of MRI changes on follow-up brain imaging <1 year versus >1 yeara
≤365 Days >365 Days No. 37 23 Median time to MRI (day) 101 (range, 5–263) 1136 (range, 382–3022) No. with recurrent hemorrhage 8 6 T1 hyperintensity 19/32 (59.4%) 8/16 (50.0%) T1 hyperintensity (moderate to significant) 10/19 (56.2%) 1/9 (11.1%) Enhancement with gadolinium 8/31 (25.8%) 9/16 (56.2%) Edema 2/32 (6.2%) 0 DWI low intensity 20/29 (68.9%) 13/16 (81.2%) ADC low intensity 19/28 (67.9%) 8/13 (61.5%) Change to Zabramski type II or III lesions 27/32 (84.4%) 16/16 (100%) Average size change (mm) (range) Median, −1.4 (−24.7 to +1.1) Median, −3.3 (−9.7 to +8.9)
↵a Denominators noted are based on the availability of the particular MRI sequence.